IQ-AI shares surge after receiving FDA clearance

Sep 27, 2019

IQ-AI (IQAI) subsidiary Imaging Biometrics received FDA clearance for its StoneChecker Software for marketing in the USA on Friday.

Imaging Biometrics develops and provides visualization and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence.

Shares in IQAI soared over 50% following the news in early morning trading in London

David Smith, Chief Executive of the operating subsidiaries of IQ-AI stated, "We are delighted that after an exhaustive review of the product, that the FDA has cleared the product for marketing in the USA."

The company said that it would make a further announcement outlining to investors the scale of the market opportunity for the product in the USA and IQ-AI’s plans to introduce it.

Follow News & Updates from IQAI here:

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Market Sectors

Rome Resources raises additional £200,000 from JLE

Panther Metals appoints Katie O’Reilly as chief financial officer

Pinnacle Silver and Gold raises $2.5 million for exploration and development work at El Potrero

Polarean Imaging secures first Xenon MRI installation in Asia

Vast Resources nets just over US$1 million in initial diamond tender

Hybridan Small Cap Feast: 25 November 2025

Hybridan Small Cap Feast: 20 November 2025

Tatton Asset Management: Research

Hybridan Small Cap Feast: 10 November 2025

Hybridan Monthly, 3 November 2025

We're in a bull market, says CQS's Robert Crayfourd

Mining Matters: Manganese in Botswana with Charlie Fitzroy of Giyani Metals

Operating in Nevada: Great Western Mining

Mining Matters: Anthony Viljoen, the CEO of Andrada Mining

Cailey Barker: Specialty metals, gold, and the state of the mining sector

IQ-AI shares surge after receiving FDA clearance